CNSP ▲ +3.5% - CNS Pharmaceuticals, Inc. $CNSP - CNS Pharmaceuticals Details Business Development Strategy Driving Its Next Phase of Growth CNS Pharmaceuticals rose 3.5% following the company's disclosure of its business development strategy aimed at advancing its growth trajectory. The announcement likely attracted investor interest by clarifying the pharmaceutical firm's strategic direction and near-term priorities. 01-SEP-2026 09:01 AM ET